Recce Pharmaceuticals Ltd. is engaged in the research and development of pharmaceutical drugs that kill germs. It produces antibiotics that are effective in attacking disease-causing Gram-positive and ...
Capital raising strengthens balance sheet for commercial licensing and ongoing clinical trials. Recce Pharmaceuticals Limited (ASX:RCE), a leading developer of synthetic anti-infectives designed to ...
Recce Pharmaceuticals, a late-stage clinical biotech company developing therapies to address antimicrobial-resistant superbugs, has launched a $10 million capital raising to complete a phase of its ...
Abstract: Time Division Multiple Access-based Medium Access Control protocols tend to be the choice for wireless networks that require deterministic delay guarantees, as is the case in many Industrial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results